108
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Use of venous-thrombotic-embolic prophylaxis in patients undergoing surgery for renal tumors: a questionnaire survey in the Nordic countries (The NORENCA-2 study)

, , , , , , , , , & show all
Pages 181-187 | Published online: 25 Oct 2018

References

  • BrotmanDJDeitcherSRLipGYMatzdorffACVirchow’s triad revisitedSouth Med J200497221321414982286
  • WhiteRHZhouHRomanoPSIncidence of symptomatic venous thromboembolism after different elective or urgent surgical proceduresThromb Haemost200390344645512958614
  • KhoranaAAMcCraeKRRisk stratification strategies for cancer-associated thrombosis: an updateThromb Res2014133Suppl 2S35S38
  • AgnelliGBolisGCapussottiLA clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS projectAnn Surg20062431899516371741
  • BergqvistDBurmarkUSFlordalPALow molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patientsBr J Surg19958244965017613894
  • RasmussenMSJørgensenLNWille-JørgensenPProlonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgeryCochrane Database Syst Rev2009211CD004318
  • NisenHJärvinenPFovaeusMContemporary treatment of renal tumors: a questionnaire survey in the Nordic countries (the NORENCA-I study)Scand J Urol201751536036628644697
  • LjungbergBBensalahKCanfieldSEAU guidelines on renal cell carcinoma: 2014 updateEur Urol201567591392425616710
  • McAlpineKBreauRHMallickRCurrent guidelines do not sufficiently discriminate venous thromboembolism risk in urologyUrol Oncol2017357457.e1457.e8
  • JordanBJMatulewiczRSTrihnBKunduSVenous thromboembolism after nephrectomy: incidence, timing and associated risk factors from a national multi-institutional databaseWorld J Urol201735111713171928516316
  • De MartinoRRGoodneyPPSpanglerELVariation in thromboembolic complications among patients undergoing commonly performed cancer operationsJ Vasc Surg20125541035.e41040.e422409858
  • AlbertsBDWolduSLWeinbergACDanzigMRKoretsRBadaniKKVenous thromboembolism after major urologic oncology surgery: a focus on the incidence and timing of thromboembolic events after 27,455 operationsUrology201484479980625156513
  • TysonMDCastleEPHumphreysMRAndrewsPEVenous thromboembolism after urological surgeryJ Urol2014192379379724594402
  • ClémentCRossiPAissiKIncidence, risk profile and morphological pattern of lower extremity venous thromboembolism after urological cancer surgeryJ Urol201118662293229722014814
  • KaraOZargarHAkcaORisks and benefits of pharmacological prophylaxis for venous thromboembolism prevention in patients undergoing robotic partial nephrectomyJ Urol201619551348135326626222
  • ViolettePDCartwrightRBrielMTikkinenKAGuyattGHGuideline of guidelines: thromboprophylaxis for urological surgeryBJU Int2016118335135827037846
  • SalujaMGillingPVenous thromboembolism prophylaxis in urology: a reviewInt J Urol201724858959328741745
  • PridgeonSAllchornePTurnerBPetersJGreenJVenous thromboembolism (VTE) prophylaxis and urological pelvic cancer surgery: a UK national auditBJU Int2015115222322925756135
  • SteriousSSimhanJUzzoRGFamiliarity and self-reported compliance with American Urological Association best practice recommendations for use of thromboembolic prophylaxis among American Urological Association membersJ Urol2013190399299823538239
  • WeinbergAWrightJDeibertCNationwide practice patterns for the use of venous thromboembolism prophylaxis among men undergoing radical prostatectomyWorld J Urol20143251313132124292076